Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
2006
NCT00265759Uploaded 10-23-2017
Available for Download
PDS UID: Breast_Allianc_2006_216
N/A
Provider Information
Provider Data DescriptionPrimary: To determine whether anastrozole, exemestane or letrozole administered for 16 to 18 weeks as neoadjuvant endocrine treatment for postmenopausal patients with stage II or stage III ER+ breast cancer should be chosen as the aromatase inhibitor arm of a future study that will compare neoadjuvant aromatase inhibitor treatment with neoadjuvant chemotherapy. Secondary: To compare the neoadjuvant treatment regimens relative to the rates of improvement in surgical outcome. To compare and confirm the radiological response rates (mammography by central radiological analysis) between these three neoadjuvant treatment regimens. To compare the relative safety of the neoadjuvant treatment regimens in terms of reported adverse events. See protocol for further details.
SponsorAlliance for Clinical Trials in Oncology
Data ProviderAlliance for Clinical Trials in Oncology
Partial set or SubsetOriginal Data
Patients in dataset622
# of Patients Control0
# of Patients Experimental377
DOIhttps://doi.org/10.34949/gg2g-wg21
CDISC StandardADS
Study ArmsBoth comparator and experimental arm data
Clinical Trials.gov Information
Brief SummaryN/A
ConditionsN/A
Intervention TypeDrug, Surgery
Drug(s)N/A
Total EnrolledN/A
RandomizationN/A
Blinding MethodN/A
Arms InterventionN/A
Secondary IDN/A
PubMed (PMID)N/A
Collaborator(s)N/A
Region(s)N/A
Age RangeN/A
Files:
PROTOCOLZ1031Prot_06Apr2015.pdf
CRFZ1031 A7 CRFS 08-09-10.pdf
DATA DICTIONARYz1031_datadictionary.docx
DATA (ACTIVE ARM)NCT00265759.csv
© 2023 Project Data Sphere
All rights reserved
Privacy PolicyTerms of Use